Panzer, Moshe – Trademark Portfolio

Entity Type: 01

Panzer, Moshe has 5 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 2 are successfully registered — a 40% registration rate. The portfolio includes marks such as FABUWOOD. Filings span 3 Nice Classification classes, with the highest activity in Class 42 (Computer & Scientific) and Class 40 (Treatment & Processing). This trademark owner is based in Brooklyn, NY.

1626 47th Street

Brooklyn, NY 11204

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Panzer, Moshe's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

40
Treatment & Processing (2 filings)

Treatment of materials

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does Panzer, Moshe have?

Panzer, Moshe has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 cancelled.

What trademark classes does Panzer, Moshe file in?

Panzer, Moshe files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 40 (Treatment & Processing), Class 35 (Advertising & Business). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Panzer, Moshe's most well-known trademarks?

Panzer, Moshe's registered trademark portfolio includes well-known marks such as FABUWOOD. These are among 2 currently registered trademarks in the portfolio.

What is Panzer, Moshe's trademark registration success rate?

Panzer, Moshe has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.